NSE BSE
samrat pharmachem ltd. stock

SAMRAT PHARMACHEM LTD. Share Price

- - (%)
- NSE: SAMRATPH

SAMRAT PHARMACHEM LTD. Share Price Update

As of the latest trading session, SAMRAT PHARMACHEM LTD. share price is currently at 340, which is up by 1.29 from its previous closing. Today, the stock has fluctuated between 337.10 and 341.80. Over the past year, SAMRAT PHARMACHEM LTD. has achieved a return of -25.84 %. In the last month alone, the return has been 0.08 %. Read More...

SAMRAT PHARMACHEM LTD. Performance

Day Range

Low337.10 High341.80
339.20

52 Week Range

Low 320.00 High 479.95
339.20

SAMRAT PHARMACHEM LTD. Share Price

530125

SAMRATPH

img img img img
No Data Available

Open Price

340.00

Prev. Close

338.70

Volume (Shares)

2475.00

Total traded value

8.40

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

SAMRAT PHARMACHEM LTD. Fundamentals


(Standalone)

Market Cap (Cr) 104.80
PE Ratio (TTM) 48.39
Book Value / Share 210.35
Beta 0.49
ROE 30.25%
EPS (TTM) 7.00
Dividend Yield 0.30%
Net Profit Qtr (Cr) 1.40

SAMRAT PHARMACHEM LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 82.68
Operating Expense 81.60
Net Profit 1.40
Net Profit Margin (%) 1.69
Earnings Per Share (EPS) 4.52
EBITDA 1.66
Effective Tax Rate (%) -0.71
Particulars DEC 2023 (Values in Cr)
Revenue 61.67
Operating Expense 61.94
Net Profit 0.34
Net Profit Margin (%) 0.55
Earnings Per Share (EPS) 1.11
EBITDA 0.53
Effective Tax Rate (%) -142.85
Particulars SEP 2023 (Values in Cr)
Revenue 79.74
Operating Expense 79.81
Net Profit -0.19
Net Profit Margin (%) -0.23
Earnings Per Share (EPS) -0.61
EBITDA 0.53
Effective Tax Rate (%) 179.16
Particulars JUN 2023 (Values in Cr)
Revenue 57.48
Operating Expense 57.08
Net Profit 0.61
Net Profit Margin (%) 1.06
Earnings Per Share (EPS) 1.98
EBITDA 1.13
Effective Tax Rate (%) 18.66
Particulars MAR 2023 (Values in Cr)
Revenue 69.18
Operating Expense 70.00
Net Profit -0.74
Net Profit Margin (%) -1.06
Earnings Per Share (EPS) -2.41
EBITDA -0.45
Effective Tax Rate (%) 6.32
Particulars MAR 2024 (Values in Cr)
Revenue 281.58
Operating Expense 280.45
Net Profit 2.16
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 7.00
EBITDA 3.86
Effective Tax Rate (%) 14.28
Particulars MAR 2023 (Values in Cr)
Revenue 310.65
Operating Expense 288.59
Net Profit 16.63
Net Profit Margin (%) 5.35
Earnings Per Share (EPS) 53.83
EBITDA 24.40
Effective Tax Rate (%) 26.18
Particulars MAR 2022 (Values in Cr)
Revenue 221.75
Operating Expense 198.78
Net Profit 17.18
Net Profit Margin (%) 7.74
Earnings Per Share (EPS) 55.62
EBITDA 24.86
Effective Tax Rate (%) 27.20
Particulars MAR 2021 (Values in Cr)
Revenue 179.02
Operating Expense 172.12
Net Profit 5.33
Net Profit Margin (%) 2.97
Earnings Per Share (EPS) 17.26
EBITDA 9.11
Effective Tax Rate (%) 27.38
Particulars MAR 2020 (Values in Cr)
Revenue 137.45
Operating Expense 132.23
Net Profit 4.24
Net Profit Margin (%) 3.08
Earnings Per Share (EPS) 13.71
EBITDA 7.19
Effective Tax Rate (%) 26.77
Particulars MAR 2023 (Values in Cr)
Book Value / Share 204.37
ROE % 30.25
ROCE % 34.91
Total Debt to Total Equity 0.24
EBITDA Margin 7.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 151.54
ROE % 44.94
ROCE % 52.32
Total Debt to Total Equity 0.21
EBITDA Margin 11.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 95.92
ROE % 19.76
ROCE % 23.90
Total Debt to Total Equity 0.34
EBITDA Margin 4.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.66
ROE % 19.11
ROCE % 22.38
Total Debt to Total Equity 0.36
EBITDA Margin 4.58
Particulars MAR 2019 (Values in Cr)
Book Value / Share 64.95
ROE % 7.98
ROCE % 11.73
Total Debt to Total Equity 0.41
EBITDA Margin 2.90
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 11.89
Total Assets 116.15
Total Liabilities 116.15
Total Equity 63.14
Share Outstanding 3089700
Price to Book Ratio 1.82
Return on Assets (%) 14.31
Return on Capital (%) 20.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 14.70
Total Assets 84.61
Total Liabilities 84.61
Total Equity 46.82
Share Outstanding 3089700
Price to Book Ratio 3.20
Return on Assets (%) 20.31
Return on Capital (%) 31.62
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.50
Total Assets 57.39
Total Liabilities 57.39
Total Equity 29.63
Share Outstanding 3089700
Price to Book Ratio 1.42
Return on Assets (%) 9.29
Return on Capital (%) 13.88
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.17
Total Assets 58.34
Total Liabilities 58.34
Total Equity 24.30
Share Outstanding 3089700
Price to Book Ratio 0.76
Return on Assets (%) 7.26
Return on Capital (%) 12.68
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 2.24
Total Assets 40.22
Total Liabilities 40.22
Total Equity 20.06
Share Outstanding 3089700
Price to Book Ratio 1.15
Return on Assets (%) 3.81
Return on Capital (%) 5.87
Particulars MAR 2023 (Values in Cr)
Net Income 22.53
Cash from Operations 0.06
Cash from Investing -3.00
Cash from Financing 9.59
Net change in Cash -2.84
Free Cash Flow 1.42
Particulars MAR 2022 (Values in Cr)
Net Income 23.60
Cash from Operations 19.00
Cash from Investing -1.06
Cash from Financing -1.94
Net change in Cash 14.46
Free Cash Flow 20.28
Particulars MAR 2021 (Values in Cr)
Net Income 7.34
Cash from Operations 7.05
Cash from Investing -2.92
Cash from Financing -1.88
Net change in Cash -0.01
Free Cash Flow 9.78
Particulars MAR 2020 (Values in Cr)
Net Income 5.78
Cash from Operations -0.45
Cash from Investing -1.92
Cash from Financing 2.00
Net change in Cash -1.24
Free Cash Flow 0.31
Particulars MAR 2019 (Values in Cr)
Net Income 2.15
Cash from Operations 4.02
Cash from Investing 2.17
Cash from Financing -3.92
Net change in Cash 0.63
Free Cash Flow 4.32
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 116.40 12.72 1.26 1219.15 77.65 / 148.95
CIPLA LTD 1505.80 28.56 4.55 121596.06 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 203.65 0.00 2.07 599.36 136.00 / 219.05
GLAXOSMITHKLINE PHARMA LT 2559.65 66.04 24.39 43362.02 1376.50 / 2759.00
SANOFI INDIA LIMITED 6432.15 26.11 14.59 14813.24 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
SAMRAT PHARMACHEM LTD. 338.70 48.39 1.61 104.66 320.00 / 479.95
AMRUTAJAN HEALTH LTD 761.05 48.91 7.62 2200.24 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6864.45 114.79 24.10 17161.13 3650.05 / 7550.00
BLISS GVS PHARMA LTD 116.40 16.01 1.23 1219.15 77.65 / 148.95
ABBOTT INDIA LIMITED 27823.05 49.22 15.98 59123.98 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 337.70
  • 26 Days 340.20
  • 10 Days 338.20
  • 50 Days 352.60
  • 12 Days 338.40
  • 100 Days 356.80
  • 20 Days 339.90
  • 200 Days 390.60
339.93
PIVOT
First Resistance 343.77
Second Resistance 348.83
Third Resistance 352.67
First Support 334.87
Second Support 331.03
Third Support 325.97
RSI 34.42
MACD -1.82
Commodity Channel Index (CCI) -43.65
ADX 10.23
Williams % R -67.59

Over 1 Month

down

0.08

Over 3 Months

down

-10.07

Over 6 Months

down

-16.78

Over 1 Year

down

-25.84

Over 3 Years

down

5.41

Over 5 Years

down

38.00

SAMRAT PHARMACHEM LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SAMRAT PHARMACHEM LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
51.36
Promoter Holdings
48.63
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Lalit Damodar Mehta Shareholding of Promoter and Promoter Group 431498.0 13.97
Rajesh Lalit Mehta Shareholding of Promoter and Promoter Group 383542.0 12.41
Premal Lalit Mehta Shareholding of Promoter and Promoter Group 175281.0 5.67
Kaushal Lalit Mehta Shareholding of Promoter and Promoter Group 139065.0 4.5
Jaya Lalit Mehta Shareholding of Promoter and Promoter Group 119300.0 3.86
Sangeetha S Public Shareholding 101000.0 3.27
Lloyds Securities Overseas Limited Public Shareholding 100000.0 3.24
Rupal Rajesh Mehta Shareholding of Promoter and Promoter Group 82182.0 2.66
Falguni Kaushal Mehta Shareholding of Promoter and Promoter Group 66400.0 2.15
Kalpana Premal Mehta Shareholding of Promoter and Promoter Group 50600.0 1.64
Megh Rajesh Mehta Shareholding of Promoter and Promoter Group 46650.0 1.51
Anshul Specialty Molecules Public Shareholding 40444.0 1.31
Sharad Kanayalal Shah Public Shareholding 35000.0 1.13
Maitri Megh Mehta Shareholding of Promoter and Promoter Group 8244.0 0.27

SAMRAT PHARMACHEM LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-18 1.0 Final 2023-09-18 Equity shares 2022-09-22 1.0 Final 2022-09-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SAMRAT PHARMACHEM LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SAMRAT PHARMACHEM LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Samrat Pharmachem Ltd?

Answer Field

The share price of Samrat Pharmachem Ltd for NSE is ₹ 0.00 and for BSE is ₹ 339.20.

What is the Market Cap of Samrat Pharmachem Ltd?

Answer Field

The market cap of Samrat Pharmachem Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 104.80 Cr. as of now.

What is the 52 Week High and Low of Samrat Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Samrat Pharmachem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 479.95 and ₹ 320.00.

How to Buy Samrat Pharmachem Ltd share?

Answer Field

You can trade in Samrat Pharmachem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Samrat Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been -25.84%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader